Company / Current Assets
Collegium Pharmaceutical, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$691.4M
FY2025
5-year range
$315.5M / $691.4M
FY2021-FY2025
Trend
+43.4%
vs FY2024
Sector context
#83 of 213
Health Care
What the data says
At $691M, Collegium Pharmaceutical, Inc.'s current assets ranks #83 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $133M in FY2017 to $691M in FY2025.
Based on SEC 10-K filings.
$691M in FY2025 with a 5-year CAGR of +20.0%.
Improved from $538M to $691M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +18.1%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Sector benchmark
#83 of 213 in Health CareTop 39% of 213This company $691.4M Sector average $2.5B
▼
-72.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.0%, indicating consistent growth.
- In FY2025, current assets increased 43.4% year-over-year.
- Ranks #83 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $691.4M | +43.4% |
| FY2024 | $482.3M | -10.3% |
| FY2023 | $537.6M | +28.0% |
| FY2022 | $420.0M | +33.1% |
| FY2021 | $315.5M | +13.6% |
| FY2020 | $277.9M | +8.7% |
| FY2019 | $255.7M | +7.7% |
| FY2018 | $237.5M | +77.9% |
| FY2017 | $133.5M | -15.8% |
| FY2016 | $158.6M | +63.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026